Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Dowd

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Annals of the Rheumatic Diseases|August 1, 1981
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosisM F Martin, P M Dowd, E F Ring, et al.
British Journal of Pharmacology|September 1, 1984
Leukotriene B4-like material in scale of psoriatic skin lesionsS D Brain, R D Camp, F M Cunningham, et al.
Clinical and Experimental Dermatology|November 1, 1991
The hormonal profile of women with acne and polycystic ovariesC B Bunker, J A Newton, G S Conway, et al.
The Journal of Investigative Dermatology|May 1, 1988
Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activityM H Rustin, H A Bull, S J Machin, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1991
Transforming growth factor alpha: in vivo release by normal human skin following UV irradiation and abrasionL C James, A M Moore, L A Wheeler, et al.
The Journal of Pathology|July 1, 1991
Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosisG Terenghi, C B Bunker, Y F Liu, et al.
The Journal of Investigative Dermatology|October 1, 1991
Endothelin-1 in human skin: immunolocalization, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cellsH A Bull, C B Bunker, G Terenghi, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skinR M Barr, A K Black, P M Dowd, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
Lancet (London, England)|October 20, 1990
Raynaud's phenomenon, calcitonin gene-related peptide, endothelin, and cutaneous vasculatureP M Dowd, C B Bunker, H A Bull, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Annals of the Rheumatic Diseases|August 1, 1981
Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosisM F Martin, P M Dowd, E F Ring, et al.
British Journal of Pharmacology|September 1, 1984
Leukotriene B4-like material in scale of psoriatic skin lesionsS D Brain, R D Camp, F M Cunningham, et al.
Clinical and Experimental Dermatology|November 1, 1991
The hormonal profile of women with acne and polycystic ovariesC B Bunker, J A Newton, G S Conway, et al.
The Journal of Investigative Dermatology|May 1, 1988
Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activityM H Rustin, H A Bull, S J Machin, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1991
Transforming growth factor alpha: in vivo release by normal human skin following UV irradiation and abrasionL C James, A M Moore, L A Wheeler, et al.
The Journal of Pathology|July 1, 1991
Image analysis quantification of peptide-immunoreactive nerves in the skin of patients with Raynaud's phenomenon and systemic sclerosisG Terenghi, C B Bunker, Y F Liu, et al.
The Journal of Investigative Dermatology|October 1, 1991
Endothelin-1 in human skin: immunolocalization, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cellsH A Bull, C B Bunker, G Terenghi, et al.
British Journal of Clinical Pharmacology|January 1, 1988
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skinR M Barr, A K Black, P M Dowd, et al.
British Journal of Rheumatology|June 1, 1988
Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogueD A Yardumian, D A Isenberg, M Rustin, et al.
Lancet (London, England)|October 20, 1990
Raynaud's phenomenon, calcitonin gene-related peptide, endothelin, and cutaneous vasculatureP M Dowd, C B Bunker, H A Bull, et al.
Pageof 13